Iran

Bashagard is an important malaria endemic area in south of Iran. An epidemiological and entomological survey was performed during 2002–2010.

To sum up, malaria case management still constitutes a public health problem in Iran.

Plasmodium falciparum remains globally an important cause of mortality and morbidity and despite decades of research, no effective vaccine is available against this deadly parasite.

Plasmodium vivax is still the more prevalent human Plasmodium outside Africa and despite this fact, there is still a deep lack of knowledge on its biology.

Malaria is still one of the most important health-problems in the world and is endemic in Iran.

These data point towards the need for addressing the exact role of TLRs in contributing to human genetic factors in malaria susceptibility/resistance/severity within different malaria settings in the world.

The aim of this report is to describe the role of injecting drug usage in malaria outbreaks occurring in malaria-free regions.

The present findings demonstrated the presence of non-variant specific antibodies to PfMSP-119 in Iranian falciparum malaria patients. This data suggests that polymorphism in PfMSP-119 is less important and one variant of this antigen, particularly Q/KNG/L, may be sufficient to be included in PfMSP-119-based vaccine.

The present data suggest the need for improving microscopy diagnosis method and the clinician should also have careful clinical observation, along with the reports on Giemsa-stained thick blood films, particularly in summer time when P. vivax is predominant.

No abstract available